Is VECT or ARCC a better dividend investment in 2026?

VECT currently yields 11.86% with a 5% 5-year dividend growth rate. ARCC yields 9.06% with 3.1% growth. The better choice depends on your goal: VECT offers higher current income.

What is the dividend yield difference between VECT and ARCC?

VECT has a forward dividend yield of 11.86% ($2.00/share annually). ARCC yields 9.06% ($1.92/share annually). The yield gap is 2.80 percentage points.

Home › Compare › VECT vs ARCC

VECT vs ARCC: Dividend Comparison 2026

VECT yields 11.86% · ARCC yields 9.06%● Live data

vsPost on X →

After 10 years · $10,000 invested · DRIP enabled

🏆 ARCC wins by $104.00 in total portfolio value· pulled ahead in Year 10

INVESTMENT

TIME HORIZON10 years

VECT

● Live price

11.86%

Share price

$16.87

Annual div

$2.00

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$43.7K

Annual income

$2,485.28

Full VECT calculator →

ARCC

Ares Capital Corporation

● Live price

9.06%

Share price

$21.20

Annual div

$1.92

5Y div CAGR

3.1%

Payout ratio

88%

After 10 yrs · $10,000 · DRIP

Portfolio value

$43.8K

Annual income

$2,279.31

Full ARCC calculator →

Portfolio growth — VECT vs ARCC

📍 ARCC pulled ahead of the other in Year 10

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis Period	VECT	ARCC
2008–2009 GFC	— No data	— No data
2020 Q1–Q2 COVID	— No data	— No data
2022 Q4 Rate Hike	— No data	— No data

Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.

📅

Dividend Calendar Overlap

Combined, VECT + ARCC cover 0 of 12 months — good coverage

Jan

—

Feb

—

Mar

—

Apr

—

May

—

Jun

—

Jul

—

Aug

—

Sep

—

Oct

—

Nov

—

Dec

—

VECT pays

ARCC pays

Both pay

Neither

💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

VECT

Annual income on $10K today (after 15% tax)

$1,007.71/yr

After 10yr DRIP, annual income (after tax)

$2,112.49/yr

ARCC

Annual income on $10K today (after 15% tax)

$769.81/yr

After 10yr DRIP, annual income (after tax)

$1,937.41/yr

At 15% tax rate, VECT beats the other by $175.07/year in after-tax income after 10 years on $10,000

⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of VECT + ARCC for your $10,000?

VECT: 50%ARCC: 50%

100% ARCC50/50100% VECT

Portfolio after 10yr

$43.8K

Annual income

$2,382.30/yr

Blended yield

5.44%

📊

Analyst Conviction Gap

Where Wall Street is most bullish on ARCC right now

VECT

Analyst Ratings

Buy

Consensus: Buy

Price Target

$18.00

+6.7% upside vs current

Range: $18.00 — $18.00

Altman Z

13.9

Piotroski

4/9

ARCC

Analyst Ratings

Buy

Hold

Consensus: Buy

Price Target

$21.88

+3.2% upside vs current

Range: $21.00 — $23.00

Altman Z

0.8

Piotroski

4/9

Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.

🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

VECT buys

ARCC buys

No recent congressional trades found for VECT or ARCC in the last 90 days.

STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →

MetricVECTARCC

Forward yield	11.86% ✓	9.06%
Annual dividend / share	$2.00 ✓	$1.92
Payout ratio	50% ✓	88%
1-year div growth	0%	2% ✓
5-year div CAGR	0%	3.1% ✓
Portfolio after 10y	$43.7K	$43.8K ✓
Annual income after 10y	$2,485.28 ✓	$2,279.31
Total dividends collected	$18.2K ✓	$15.5K
Payment frequency	quarterly	quarterly
Sector	Stock	BDC
Analyst consensus	Buy	Buy
Analyst price target	$18.00	$21.88 ✓

Year-by-year: VECT vs ARCC ($10,000, DRIP)

Year	VECT Portfolio	VECT Income/yr	ARCC Portfolio	ARCC Income/yr	Gap
1	$11,886	$1,185.54	$11,774	$933.74	+$112.00 → VECT
2	$14,034	$1,316.89	$13,808	$1,045.61	+$226.00 → VECT
3	$16,470	$1,453.25	$16,135	$1,166.34	+$335.00 → VECT
4	$19,217	$1,593.89	$18,786	$1,296.19	+$431.00 → VECT
5	$22,300	$1,738.05	$21,800	$1,435.41	+$500.00 → VECT
6	$25,746	$1,884.96	$25,215	$1,584.23	+$531.00 → VECT
7	$29,582	$2,033.87	$29,076	$1,742.84	+$506.00 → VECT
8	$33,837	$2,184.03	$33,430	$1,911.44	+$407.00 → VECT
9	$38,540	$2,334.73	$38,328	$2,090.21	+$212.00 → VECT
10← crossover	$43,723	$2,485.28	$43,827	$2,279.31	$104.00 → ARCC

VECT vs ARCC: Complete Analysis 2026

VECT — Stock

VectivBio Holding AG, a clinical stage biopharmaceutical company, focuses on the discovery, development, and commercialization of medicines for treatments of severe rare conditions. It develops apraglutide, a long-acting synthetic peptide analog of glucagon-like peptide-2 that is in Phase III clinical trial for the treatment of patients with short bowel syndrome-intestinal failure (SBS-IF), as well as apraglutide is in Phase II clinical trial for SBS-IF in patients with colon-in-continuity anatomy. The company is also developing apraglutide, which is in Phase II clinical trial for patients with steroid-refractory gastrointestinal acute versus host disease (aGvHD). The company was incorporated in 2019 and is headquartered in Basel, Switzerland.

Full VECT Calculator →

ARCC — BDC

Ares Capital is the largest Business Development Company by assets. It provides financing to middle market companies and pays a generous quarterly dividend plus occasional special dividends. With $21B+ in AUM and diversified exposure across industries, ARCC is the benchmark BDC for income investors.

Full ARCC Calculator →

📬

Get this VECT vs ARCC comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

VECT vs SCHD VECT vs JEPI VECT vs O VECT vs KO VECT vs MAIN VECT vs HTGC VECT vs GBDC VECT vs ORCC

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.